Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Healthcare
Ligand Pharmaceuticals Inc. Cash on Hand 2009–2025
Ligand Pharmaceuticals Inc. annual cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Ligand Pharmaceuticals Inc. cash on hand as of December 31, 2025: 174.9M, a 141.92% increase year-over-year.
- Ligand Pharmaceuticals Inc. cash on hand for 2025 were 174.9M, a 141.92% increase from 2024.
- Ligand Pharmaceuticals Inc. cash on hand for 2024 were 72.3M, a 215.01% increase from 2023.
- Ligand Pharmaceuticals Inc. cash on hand for 2023 were 23.0M, a 49.00% decrease from 2022.
- Ligand Pharmaceuticals Inc. cash on hand for 2022 were 45.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ligand Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $175 |
| 2024 | $72 |
| 2023 | $23 |
| 2022 | $45 |
| 2021 | $20 |
| 2020 | $48 |
| 2019 | $72 |
| 2018 | $117 |
| 2017 | $21 |
| 2016 | $19 |
| 2015 | $97 |
| 2014 | $160 |
| 2013 | $12 |
| 2012 | $12 |
| 2011 | $7 |
Ligand Pharmaceuticals Inc. Cash on Hand — FAQ
Ligand Pharmaceuticals Inc. (LGND) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LGND's cash on hand history?
The chart and table above show Ligand Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.